Related Experiment Video
Updated: May 15, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
The history of pediatric allergy in Europe - from a working group to ESPACI and SP-EAACI
Sten Dreborg1, Graham Roberts, Susanne Lau
1Department of Pediatric Allergy, Women's and Children's Health, University of Uppsala, Uppsala, Sweden. sten.dreborg@kbh.uu.se
Insights
The European Society on Pediatric Allergology and Clinical Immunology (ESPACI) evolved into the Pediatric Section of the European Academy of Allergology and Clinical Immunology (EAACI). This section advances pediatric allergy care through education, research, and advocacy for children.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Immunology
- European Health Organizations
Background:
- The European Society on Pediatric Allergology and Clinical Immunology (ESPACI) was established in 1984, evolving from a working group.
- ESPACI launched its own journal, Pediatric Allergology and Immunology, in 1988.
- ESPACI collaborated with the European Academy of Allergology and Clinical Immunology (EAACI) to form the Section of Pediatrics within EAACI (SP-EAACI) in 1996.
Abstract:
A Working Group on Pediatric Allergology was formed in 1984, which rapidly developed to become the European Society on Pediatric Allergology and Clinical Immunology (ESPACI) in 1988 with its own journal, Pediatric Allergology and Immunology. ESPACI worked together with the European Academy of Allergology and Clinical Immunology (EAACI) to form a Section of Pediatrics within EAACI (SP-EAACI) in 1996. The ESPACI and the SP-EAACI formally merged in 2001. Within the EAACI organization, the Pediatric Section has continued to grow. The Pediatric Section is working to develop pediatric allergology across Europe, focusing on postgraduate education, facilitating the research agenda and advocating for children and adolescents with allergies.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Allergic Drug Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

